Ben Ho Park

Also affiliated with Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

14.6Author DataRank

Indexed papers

7in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 7 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Consensus Coding Sequences of Human Breast and Colorectal Cancers

Science(2006)10.1126/science.1133427

Top 1%

11.9DataRank

Top 1%3178 citations

Siân Jones, Laura D. Wood, D. Williams Parsons, Jimmy Lin, Thomas D. Barber +26 more

Papers

Driven by 48 papers — median percentile 17. Top paper: “The Consensus Coding Sequences of Human Breast and Colorectal Cancers”.

The Consensus Coding Sequences of Human Breast and Colorectal Cancers

Science(2006)10.1126/science.1133427

Top 1%

11.9DataRank

Top 1%3178 citations

Siân Jones, Laura D. Wood, D. Williams Parsons, Jimmy Lin, Thomas D. Barber +26 more

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-19-4191

N/A

4.0DataRank · unranked

96 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x

Top 9%

2.4DataRank

Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

Characteristics and Outcome of AKT1 E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1209

N/A

2.3DataRank · unranked

51 citations

Qin Zhou, Bastien Nguyen, Celeste Yu, Eva M. Lepisto, Mónica Arnedos +27 more

Systemic inhibition of PTPN22 augments anticancer immunity

Journal of Clinical Investigation(2021)10.1172/jci146950

N/A

1.3DataRank · unranked

55 citations

Sarah Croessmann, Jianping Lin, Zaw Phyo, Soren Charmsaz, Ludmila Danilova +18 more

Circulating tumor DNA: current challenges for clinical utility

Journal of Clinical Investigation(2022)10.1172/jci154941

N/A

0.805DataRank · unranked

213 citations

Ben Ho Park, Donna K. Dang

CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2598

N/A

0.678DataRank · unranked

91 citations

Sarah Croessmann, Ben Ho Park, Sarah C. Reed

Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data

JCO Clinical Cancer Informatics(2024)10.1200/cci.23.00207

N/A

0.500DataRank · unranked

27 citations

Kathleen F. Mittendorf, Zoltán Kiss, Michele L. Lenoue-Newton, Pablo Napan-Molina, Protiva Rahman +17 more

Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-0781

N/A

0.483DataRank · unranked

24 citations

Ayca Nazli Mogol, Yu-Jeh Liu, Ashlie Santaliz Casiano, Christine Chien, Jenny Drnevich +13 more

Targeting ESR1 mutation–induced transcriptional addiction in breast cancer with BET inhibition

JCI Insight(2022)10.1172/jci.insight.151851

N/A

0.396DataRank · unranked

13 citations

Qian Wang, Sunil Kumar, Venkat S. Malladi, Szu‐Yuan Wu, Shuguang Wei +19 more

Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair

Communications Biology(2021)10.1038/s42003-021-02370-0

N/A

0.385DataRank · unranked

12 citations

Moyi Wang, Mohammed Alruwaili, Brandon E. Smith, Megan Melnick, Kevin H. Eng +6 more

A randomized phase III post-operative trial of platinum-based chemotherapy (P) versus capecitabine (C) in patients (pts) with residual triple-negative breast cancer (TNBC) following neoadjuvant chemotherapy (NAC): ECOG-ACRIN EA1131

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.605

N/A

0.312DataRank · unranked

7 citations

Fengmin Zhao, Carlos L. Arteaga, W. Fraser Symmans, Ben Ho Park, Brian L. Burnette +12 more

Hotspot ESR1 mutations are multimodal and contextual drivers of breast cancer metastasis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.10.430701

N/A

0.292DataRank · unranked

6 citations

Yang Wu, Megan E. Yates, Nilgun Tasdemir, Amir Bahreini, Jian Chen +31 more

Feasibility and Tolerability of Adjuvant Capecitabine-Based Chemoradiation in Patients With Breast Cancer and Residual Disease After Neoadjuvant Chemotherapy: A Prospective Clinical Trial

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2023.06.076

N/A

0.269DataRank · unranked

5 citations

Alexander D. Sherry, Brent N. Rexer, Vandana G. Abramson, Kenneth J. Niermann, Corbin R. Johnson +4 more

Reply to T. Shimoi et al and Y. Shimanuki et al

Journal of Clinical Oncology(2021)10.1200/jco.21.01905

N/A

0.209DataRank · unranked

2 citations

Fengmin Zhao, Carlos L. Arteaga, W. Fraser Symmans, Ben Ho Park, Brian L. Burnette +20 more

Clonal Hematopoiesis of Indeterminate Potential After Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.10.006

N/A

0.208DataRank · unranked

3 citations

Sydney Olson, Yajing Li, Cosmin A. Bejan, Caitlyn Vlasschaert, Taralynn Mack +11 more

Clonal Hematopoiesis of Indeterminate Potential Influences Breast Cancer Outcomes in a Genotype-Specific Manner

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-2009

N/A

0.208DataRank · unranked

3 citations

Chad R. Potts, Leo Y. Luo, Brad A. Davidson, Riley E. Bergman, J. Kemp +14 more

Adjuvant platinum versus capecitabine for residual, invasive, triple‐negative breast cancer: Patient‐reported outcomes in ECOG‐ACRIN EA1131

Cancer(2024)10.1002/cncr.35187

N/A

0.208DataRank · unranked

3 citations

Fengmin Zhao, Ingrid A. Mayer, Amyé Tevaarwerk, Sofia F. Garcia, Carlos L. Arteaga +20 more

Pan-Cancer Analyses Reveal Disparities in Tumor Genomic Profiles by Race/Ethnicity, Age, and Sex

Cancer Epidemiology Biomarkers & Prevention(2025)10.1158/1055-9965.epi-25-0345

Top 65%

0.204DataRank

Top 65%2 citations

Jung Yoon Choi, Bhuminder Singh, Li Li, Adetunji T. Toriola, Kristen K. Ciombor +6 more

Proteomic Analysis of PTEN-Deficient Cells Reveals Src-Mediated Upregulation of EphA2 and Therapeutic Potential of Dual Inhibition

Molecular & Cellular Proteomics(2025)10.1016/j.mcpro.2025.101316

N/A

0.104DataRank · unranked

1 citations

Xiangyi Kong, Hongming Song, Li Wang, Lingrui Li, Xiaonan Hou +14 more

Risk of Clonal Hematopoiesis of Indeterminate Potential after Cancer Radiation Therapy

medRxiv(2024)10.1101/2024.09.27.24314321

N/A

0.104DataRank · unranked

1 citations

Sydney S Olson, Yajing Li, Cosmin A. Bejan, Caitlyn Vlasschaert, T. Mack +11 more

A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice

Science Translational Medicine(2021)10.1126/scitranslmed.abf1383

N/A

0DataRank · unranked

35 citations

Darjan Duraki, Lawrence Wang, Chengjian Mao, Ji Eun Kim, Madeline Henn +15 more

Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer

UNC Libraries(2020)10.17615/jyfd-8k67

N/A

0DataRank · unranked

0 citations

Meghan M. Morrison, Rebecca S. Cook, Dana M. Brantley‐Sieders, D.C. Liebler, Joyce O’Shaughnessy +23 more

NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model

Oncotarget(2022)10.18632/oncotarget.28200

N/A

0DataRank · unranked

7 citations

Morgan V. Pantone, Dong Ho Shin, Riley E. Bergman, Rory L. Cochran, David Chu +15 more

Plasma Membrane Channel TRPM4 Mediates Immunogenic Therapy–Induced Necrosis

Cancer Research(2023)10.1158/0008-5472.can-23-0157

N/A

0DataRank · unranked

29 citations

Rachel Yang, Darjan Duraki, Junyao Zhu, Ji Eun Kim, Musarrat Jabeen +9 more

Data from Deletion of PTEN Promotes Tumorigenic Signaling, Resistance to Anoikis, and Altered Response to Chemotherapeutic Agents in Human Mammary Epithelial Cells

(2023)10.1158/0008-5472.c.6499844.v1

N/A

0DataRank · unranked

0 citations

Michele B. Weiss, Marta Szmacinski, Khola Tahir, Todd Waldman, Ben Ho Park +4 more

Data from Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis

(2023)10.1158/0008-5472.c.6513817.v1

N/A

0DataRank · unranked

0 citations

Yang‐Chang Wu, Megan E. Yates, Nilgun Tasdemir, Amir Bahreini, Jian Chen +34 more

Data from Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

(2023)10.1158/1078-0432.c.6530603

N/A

0DataRank · unranked

0 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

Data from Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

(2023)10.1158/1078-0432.c.6530603.v1

N/A

0DataRank · unranked

0 citations

Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan +25 more

Supplementary Table from A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22432374.v1

Top 100%

0DataRank

Top 100%0 citations

Suryavathi Viswanadhapalli, Monica Mann, Dimple Chakravarty, Samaya Krishnan, Zexuan Liu +21 more

Data from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy

(2023)10.1158/1541-7786.c.6545651

N/A

0DataRank · unranked

0 citations

Ayca Nazli Mogol, Yu-Jeh Liu, Ashlie Santaliz Casiano, Christine Chien, Jenny Drnevich +13 more

Supplementary Table from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy

(2023)10.1158/1541-7786.22528217

Top 100%

0DataRank

Top 100%0 citations

Ayca Nazli Mogol, Yu-Jeh Liu, Ashlie Santaliz Casiano, Christine Chien, Jenny Drnevich +13 more

A prospective study evaluating the association of patient-reported outcomes with activity level and sleep patterns in sarcoma survivors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12085

Top 100%

0DataRank

Top 100%0 citations

Emma Schremp, Tatsuki Koyama, Lili Sun, Lauren King, Vicki L. Keedy +7 more

Next generation sequencing reveals targetable mutations in multiple sarcoma histologies.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11548

N/A

0DataRank · unranked

0 citations

Michael H. Robinson, Lauren A. King, Emma Schremp, Adam X. Miranda, Juan M. Colazo +7 more

Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors

Breast Cancer Research and Treatment(2020)10.1007/s10549-020-05629-y

N/A

0DataRank · unranked

11 citations

Yvonne Ziegler, Sayyed Hamed Shahoei, Parama Dey, Sung Hoon Kim, Mayuri A. Yasuda +6 more

An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release

Communications Biology(2024)10.1038/s42003-024-06129-1

N/A

0DataRank · unranked

18 citations

Adam X. Miranda, Sarah C. Reed, Riley E. Bergman, Justin Kemp, Anvith P. Reddy +7 more

Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations

BMC Genomics(2024)10.1186/s12864-024-10368-1

N/A

0DataRank · unranked

4 citations

Justin Kemp, Brad A. Davidson, Sara E. Bellomo, Verda E. Miranda, Alexandra A Manoni +5 more

Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.03.574067

N/A

0DataRank · unranked

0 citations

Justin Kemp, Brad A. Davidson, Sara E. Bellomo, Verda Agan, Alexandra A Manoni +5 more

Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancer

JCI Insight(2025)10.1172/jci.insight.187151

N/A

0DataRank · unranked

2 citations

Hong Yuen Wong, Jorgen Jackson, Monika Antunovic, Brenda Rios, Evan Watkins +17 more

Distinct and convergent effects of SF3B1 mutations in human breast cancer

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2505374122

N/A

0DataRank · unranked

0 citations

Christin I. Keeton, Irika R. Sinha, Jonathan P. Ling, Yu Wang, Lauren Ha +17 more

Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones

Journal of Clinical Investigation(2021)10.1172/jci143557

N/A

0DataRank · unranked

17 citations

Ian Waters, Lauren Dennison, David Chu, Joshua Donaldson, Dong Ho Shin +17 more

Circulating Free Tumor DNA (ctDNA): The Real-Time Liquid Biopsy

Cancer Drug Discovery and Development(2017)10.1007/978-3-319-50956-3_6

N/A

0DataRank · unranked

0 citations

Ben Ho Park, Kelly Kyker-Snowman

Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes

Clinical Breast Cancer(2021)10.1016/j.clbc.2021.12.007

N/A

0DataRank · unranked

15 citations

Neha Mangini, John H. Fetting, Deborah K. Armstrong, Isaac S. Chan, Roisín M. Connolly +13 more

Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease

Nature Communications(2022)10.1038/s41467-022-33780-1

N/A

0DataRank · unranked

125 citations

Quanhu Sheng, Amanda B. Hesterberg, Sarah Croessmann, Brenda Rios, Khem Raj Giri +19 more

Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not Fluorouracil

Molecular Pharmacology(2021)10.1124/molpharm.120.000191

N/A

0DataRank · unranked

15 citations

Anthony S. Gizzi, Junru Cui, Matthew Egleston, Kyle J. Seamon, Michael DePasquale +4 more

The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer

British Journal of Cancer(2021)10.1038/s41416-021-01422-w

N/A

0DataRank · unranked

30 citations

Sarah Croessmann, Ben Ho Park, Brad A. Davidson

Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis

Cancer Research(2022)10.1158/0008-5472.can-21-2576

N/A

0DataRank · unranked

86 citations

Yang Wu, Megan E. Yates, Nilgun Tasdemir, Amir Bahreini, Jian Chen +34 more

A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-0698

N/A

0DataRank · unranked

27 citations

Suryavathi Viswanadhapalli, Monica Mann, Dimple Chakravarty, Samaya Krishnan, Zexuan Liu +21 more

Ben Ho Park

Indexed papers

Top data-sharing exemplar

Papers